TP53 and neoplasm: In addition, the small-molecule compound APR-246 and the novel condensed aminothiourea derivative COTI-2 can reactivate the TP53 gene by promoting the refolding of the mutated TP53, thus restoring the tumor suppressor effect of TP53 [8].